Donna See is the Chief Business Officer of TARA Biosystems. She brings over 15 years of experience in life sciences business development and startup operations. She was previously the Chief Business Officer of Allied-Bristol Life Sciences, a $110M therapeutic development effort led by Allied Minds and Bristol-Myers Squibb, and served as a Vice President of Investments at Allied Minds, a publicly-traded (LSE: ALM) seed investor and company builder.
Prior to that, Donna co-founded and steered the sale of Vixen Pharmaceuticals, a company dedicated to the treatment of autoimmune skin disorders, acquired by Aclaris Therapeutics (NASDAQ: ACRS). She was also a Director at Columbia Technology Ventures and founder of a biomedical accelerator fund at Columbia University. Donna received her MBA from Columbia University and BA from The Johns Hopkins University. Donna is based out in New York City.